Frequency News and Research

RSS

Psychiatrists urged to monitor metabolic changes in psychosis patients

Japanese psychiatrists are largely aware of the metabolic abnormalities that may arise from antipsychotic treatment, but most do not monitor their patients sufficiently, research shows.

30 Jan 2014

Simple hypomania checklist detects bipolar II disorder

A 15-item hypomania checklist has shown potential for differentiating bipolar disorder, particularly type II, from major depressive disorder.

30 Jan 2014

Spontaneous tumorigenic transformation of human MSCs can occur during cell culture expansion

Researchers at Erasmus University Medical Center Rotterdam, The Netherlands, led by Dr. Qiuwei Pan and Dr. Luc van der Laan, have discovered that spontaneous tumorigenic transformation of human mesenchymal stem/stromal cells (MSCs) can occur during cell culture expansion, although the frequency is relatively low and often only observed after extensive passage in culture.

30 Jan 2014

Researches analyse effectiveness of training in physical improvement of sportspeople

During his research, carried out at the NUP/UPNA-Public University of Navarre, he conducted five studies on 361 participants: four on male football players between the ages of 10 and 17, one on distance and middle-distance runners, adult men and women.

30 Jan 2014

REM sleep, memory and depression: an interview with Dr Penny Lewis, University of Manchester

Usually you don’t go into REM until you’ve passed through all the other stages of sleep. The stage immediately before REM is slow-wave sleep.

From The University of Manchester 29 Jan 2014

Patients perceive voice changes after rhinoplasty, says study

Patients who have undergone plastic surgery to change the appearance of their nose may also notice changes in the sound of their voice, reports a study in the February issue of Plastic and Reconstructive Surgery-, the official medical journal of the American Society of Plastic Surgeons (ASPS).

29 Jan 2014

FDA approves Teva's sNDA for three-times-a-week COPAXONE 40mg/mL

Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has approved the Company's supplemental new drug application for three-times-a-week COPAXONE 40mg/mL, a new dose of COPAXONE.

28 Jan 2014

Study: Nightmares have greater emotional impact than bad dreams do

According to a new study by researchers at the University of Montreal, nightmares have greater emotional impact than bad dreams do, and fear is not always a factor. In fact, it is mostly absent in bad dreams and in a third of nightmares.

28 Jan 2014

Researchers discover association between spatial neglect post stroke and long-term recovery of mobility

Stroke rehabilitation researchers at Kessler Foundation report an association between acute, severe spatial neglect post stroke and long-term recovery of mobility. This new study indicates that severity of spatial neglect during the acute inpatient rehabilitation for right brain stroke may predict functional mobility in the community after discharge.

28 Jan 2014

BRAF mutations rare in Japanese NSCLC patients

Research in a Japanese cohort of patients with non-small-cell lung cancer indicates that the frequency of BRAF mutations is low and their presence has limited prognostic significance.

27 Jan 2014

South Korean lung SCC genetic secrets revealed

Close examination of DNA taken from squamous cell carcinoma of the lung in South Korean patients has identified a gene fusion that may be targeted by current treatments, scientists say.

27 Jan 2014

New data on extending the serum half-life of albumin in vivo announced by Novozymes Biopharma

...

27 Jan 2014

Researchers examine role of white coats and neck ties in transmission of infection

In a move to reduce health care associated infections, certain attire for health care professionals, including the traditional white coat, could become a thing of the past.

27 Jan 2014

Hols conveys product’s safety and cost effectiveness to managed care groups

Health Outcomes Liaisons (HOLs) play a critical role in conveying a therapy's safety and cost effectiveness to managed care groups. With billions in sales riding on effectively communicating with these organizations regarding products' cost effectiveness and safety, the biopharmaceutical industry has turned to HOLs to fill this critical communication role.

27 Jan 2014

Researcher examines relationship between religiosity and "love" of neighbors

Most religions teach their followers to "Love thy neighbor" - including those of different races, nationalities or beliefs. But is religiousness really related to love of neighbors?

25 Jan 2014

Westone to launch TRU hearing protection earpieces at 2014 NAMM Show

Westone, the leader in high performance audio and in-ear monitoring technology, will launch their TRU™ Custom and Universal hearing protection earpieces at the 2014 NAMM Show.

25 Jan 2014

Large-scale analysis of over 20 tumor types increases catalog of cancer genes by 25%

A landmark study across many cancer types reveals that the universe of cancer mutations is much bigger than previously thought. By analyzing the genomes of thousands of patients' tumors, a Broad Institute-led research team has discovered many new cancer genes - expanding the list of known genes tied to these cancers by 25 percent. Moreover, the study shows that many key cancer genes still remain to be discovered.

25 Jan 2014

Specialists identify opportunities to reduce unnecessary first cesarean deliveries

A recently published article, based on a workshop, Preventing the First Cesarean Delivery: Summary of a Joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, and the American College of Obstetricians and Gynecologists Workshop, outlines a collaboration of specialists providing obstetrical care in helping to identify opportunities to reduce unnecessary first cesarean deliveries.

25 Jan 2014

First patient enrolled pilot clinical trial of NovoTTF Therapy plus gemcitabine for pancreatic adenocarcinoma

Novocure announced today that the first patient has enrolled in the EF-20 Study, an open label, pilot clinical trial of NovoTTF Therapy plus gemcitabine as first-line therapy for patients with locally advanced and metastatic pancreatic adenocarcinoma.

25 Jan 2014

Bristol-Myers Squibb fourth quarter 2013 revenues increase 6% to $4.4 billion

Bristol-Myers Squibb Company today reported results for the fourth quarter and full year of 2013. The fourth quarter was highlighted by the company's announcement to sell its diabetes business as part of the continued evolution of its successful BioPharma strategy to a specialty care model. The company achieved important regulatory milestones in the quarter for Eliquis in the U.S., daclatasvir/asunaprevir in Japan, daclatasvir in Europe and Farxiga in the U.S. In addition, the company provided financial guidance for 2014.

24 Jan 2014

Frequency News and Research

Psychiatrists urged to monitor metabolic changes in psychosis patients

Simple hypomania checklist detects bipolar II disorder

Spontaneous tumorigenic transformation of human MSCs can occur during cell culture expansion

Researches analyse effectiveness of training in physical improvement of sportspeople

REM sleep, memory and depression: an interview with Dr Penny Lewis, University of Manchester

Patients perceive voice changes after rhinoplasty, says study

FDA approves Teva's sNDA for three-times-a-week COPAXONE 40mg/mL

Study: Nightmares have greater emotional impact than bad dreams do

Researchers discover association between spatial neglect post stroke and long-term recovery of mobility

BRAF mutations rare in Japanese NSCLC patients

South Korean lung SCC genetic secrets revealed

New data on extending the serum half-life of albumin in vivo announced by Novozymes Biopharma

Researchers examine role of white coats and neck ties in transmission of infection

Hols conveys product’s safety and cost effectiveness to managed care groups

Researcher examines relationship between religiosity and "love" of neighbors

Westone to launch TRU hearing protection earpieces at 2014 NAMM Show

Large-scale analysis of over 20 tumor types increases catalog of cancer genes by 25%

Specialists identify opportunities to reduce unnecessary first cesarean deliveries

First patient enrolled pilot clinical trial of NovoTTF Therapy plus gemcitabine for pancreatic adenocarcinoma

Bristol-Myers Squibb fourth quarter 2013 revenues increase 6% to $4.4 billion

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News